[New adrenergic beta receptor blockader: practolol. Its effect in the treatment of coronary insufficiency].
D000083:Acetanilides / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D004562:Electrocardiography; D005080:Exercise Test; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D010101:Oxygen Consumption / Q000187:drug effects; D011437:Propylamines / Q000627:therapeutic use; D012129:Respiratory Function Tests
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D011437:Propylamines
Un nouvel inhibiteur des recepteurs beta-adrenergiques: le practolol. Son Action dans le traitement de l'insuffisance coronaire.